Protagenic Therapeutics, Inc.new (PTIX) Return on Assets [ROA] (2009 - 2026)
Protagenic Therapeutics, Inc.new's Return on Assets [ROA] came in at 223.58% for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 52.94 percentage points from the prior quarter.
Protagenic Therapeutics, Inc.new (PTIX) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Protagenic Therapeutics, Inc.new's Return on Assets [ROA] was 73.16%, up 424.45 percentage points from FY2025.
- Return on Assets [ROA] carries a five-year change of +150.22 percentage points (FY2021 to FY2026).
- Going back by fiscal year, Return on Assets [ROA] was -351.28% in FY2025, -176.51% in FY2024 (-104.71 pp), -71.79% in FY2023 (-30.07 pp) and -41.72% in FY2022 (+35.33 pp).
- The fiscal Q2 2027 figure represents the highest quarterly Return on Assets [ROA] in data going back to fiscal Q1 2015.
- Business Quant data shows PTIX's Return on Assets [ROA] at 170.64% (Q1 2027), 34.73% (Q4 2026) and -108.56% (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 2.00% |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -4.70 Mn | - | 223.58% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 223.58% |
| Jun 30, 2026 | 170.64% |
| Mar 31, 2026 | 34.73% |
| Dec 31, 2025 | -108.56% |
| Mar 31, 2025 | -524.27% |
| Dec 31, 2024 | -324.35% |
| Sep 30, 2024 | -352.01% |
| Jun 30, 2024 | -294.01% |
| Mar 31, 2024 | -158.35% |
| Dec 31, 2023 | -90.96% |
| Sep 30, 2023 | -63.61% |
| Jun 30, 2023 | -49.24% |
| Mar 31, 2023 | -40.00% |
| Dec 31, 2022 | -48.91% |
| Sep 30, 2022 | -49.65% |
| Jun 30, 2022 | -43.34% |
| Mar 31, 2022 | -47.05% |
| Dec 31, 2021 | -40.50% |
| Sep 30, 2021 | -35.04% |
| Jun 30, 2021 | -70.50% |
Protagenic Therapeutics, Inc.new Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();